Dishman Carbogen Amcis announced that its wholly owned subsidiary, Carbogen Amcis AG, successfully completed its first US Food and Drug Administration inspection at its manufacturing site in Vionnaz, Switzerland.

The inspection concluded on September 11, 2026, with no observations raised by the regulator. The facility did not receive a Form 483 notice, which is typically issued for significant violations or deficiencies found during such audits.

Regulatory Compliance

The company disclosed the outcome pursuant to Regulations 30 and 51 of the SEBI (LODR) Regulations, 2015. The successful clearance underscores the subsidiary’s adherence to strict quality parameters required for the US market.

Dishman Carbogen Amcis stated that this result reflects the company’s strong focus on quality across its global operations. All manufacturing sites worldwide remain approved by major regulatory agencies.

What the Numbers Show

The absence of a Form 483 is a critical operational indicator. In pharmaceutical manufacturing, receiving no observations during a first-time FDA inspection suggests robust process validation and quality control systems are already in place, reducing the risk of future regulatory holds or export bans for products manufactured at the Vionnaz facility.

Dishman Carbogen Amcis has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The filing provides a comprehensive overview of the company’s environmental, social, and governance performance across its operations.

The report highlights that export sales constituted 94.94% of total net sales during FY26. The company operates as a Contract Development and Manufacturing Organisation (CDMO), with 100% of its turnover derived from the manufacturing of bulk drugs and APIs.

What the Numbers Show

A notable divergence exists in employee welfare coverage between permanent staff and contract workers. While 100% of permanent employees received health insurance, 0% of the 715 non-permanent workers were covered by health insurance, though all workers had accident insurance coverage.

Environmental Metrics

The company reported total energy consumption of 109,381.64 GJ, primarily from non-renewable sources. Water withdrawal increased to 117,466 kilolitres from 85,253 kilolitres in the previous year, driven by a significant rise in third-party water usage. Total waste generated decreased to 1,382.93 metric tonnes from 1,978.03 metric tonnes in FY25.

Social & Governance Updates

Training coverage expanded significantly. Health and safety training reached 94.21% of permanent employees and workers, up from 65.47% previously. Human rights training coverage rose to 88.87%. The company reported zero complaints regarding sexual harassment, discrimination, or child labour. No penalties or fines were imposed on the company or its directors during the year.

• Turnover for CSR applicability was ₹194.52 crore.
• Net worth stood at ₹3,882.23 crore.
• Zero liquid discharge systems are operational at Bavla and Naroda sites.